Michael R Grever

8PUBLICATIONS

41CO-AUTHORS

Haematological tumoursInnate immunityCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Haematology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (8)

Sort by Publication Date:

|Jun 25, 2026

Outcomes of patients with chronic lymphocytic leukemia discontinuing covalent Bruton tyrosine kinase inhibitors due to adverse events.

|Oct 17, 2024

Incidence, description, and timing of serious and opportunistic infections in patients with hairy cell leukemia.

Nilesh Kapoor, Qiuhong Zhao, Andrew Stiff

|Aug 17, 2024

Atrial fibrillation burden and clinical outcomes following BTK inhibitor initiation.

John Alan Gambril, Sanam M Ghazi, Stephen Sansoterra

|Jun 08, 2024

Hairy cell leukemia variant and WHO classification correspondence Re: 5<sup>th</sup> edition WHO classification haematolymphoid tumors: lymphoid neoplasms.

Michael Grever, Leslie Andritsos, Mirela Anghelina

|Jul 14, 2022

Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes.

Jonathan M Hyak, Ying Huang, Kerry A Rogers

|Dec 28, 2020

The revised guidelines for the diagnosis and management of hairy cell leukaemia and the hairy cell leukaemia variant.

Xavier Troussard, Michael R Grever

Pageof 2

Frequent Collaborators

Jennifer Woyach

John C Byrd

James S Blachly

Narendranath Epperla

Alessandro Broccoli

Monica Else

Francesco Forconi

Alessandro Gozzetti

Tyler Everhart

David J Hermel

Frequent Collaborators

Jennifer Woyach

John C Byrd

James S Blachly

Narendranath Epperla